Corpus Intelligence IC Memo — FORREST GENERAL HOSPITAL 2026-04-26 03:49 UTC
IC Memo — FORREST GENERAL HOSPITAL
Investment Committee Memorandum | MS | 435 beds | Grade C | EBITDA uplift $32.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FORREST GENERAL HOSPITAL

CCN 250078 | FORREST, MS | 435 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

FORREST GENERAL HOSPITAL is a 435-bed suburban community hospital in FORREST, MS with $446.8M in net patient revenue and a -8.4% operating margin. The hospital serves a payer mix of 28.1% Medicare, 21.8% Medicaid, and 50.1% commercial.

Thesis: Undervalued. Our ML models identify $32.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.4% to -1.1% (+736bps).

Net Revenue HCRIS$446.8M
Current EBITDA COMPUTED$-37.7M
Operating Margin COMPUTED-8.4%
Occupancy HCRIS70.9%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS28.5%
Distress Probability ML48.9%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
10
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of -8.4% places it above the state median. Among 10 size-comparable peers (218-870 beds), the median margin is -11.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (218-870), prioritizing same-state peers. 10 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FORREST GENERAL HOSPITAL (Target)MS435$446.8M-8.4%
UNIVERSITY OF MISSISSIPPI MEDIMS745$1.06B-3.0%
NORTH MISSISSIPPI MEDICAL CENTMS489$747.5M-5.5%
MEMORIAL HOSPITAL AT GULFPORTMS278$700.2M-15.7%
MS BAPTIST MEDICAL CENTERMS399$449.3M-9.6%
SINGING RIVER HEALTH SYSTEMMS294$415.9M-12.8%
ST. DOMINIC-JACKSON MEMORIAL HMS526$367.3M-50.0%
BAPTIST MEM HOSPITAL DESOTOMS298$301.6M-5.2%
JEFF ANDERSON REGIONAL MEDICALMS270$213.3M-25.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $32.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$9.4M+210bp18mo
Cost to Collect4.5%2.5%$8.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$8.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$5.4M+122bp9mo
Clean Claim Rate88.0%96.0%$286K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$9.4M
Cost to Collect
$8.9M
Denial Rate Reduction
$8.8M
A/R Days Reduction
$5.4M
Clean Claim Rate
$286K
Total EBITDA Uplift$32.9M
Current EBITDA$-37.7M
+ RCM Uplift+$32.9M
Pro Forma EBITDA$-4.9M
Current Margin-8.4%
Pro Forma Margin-1.1%
WC Released (1x)$17.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-58.1M$79.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-58.1M$69.0M0.00x-100.0%
Bull Case9.0x11.0x$-52.3M$158.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-52.3M$157.7M0.00x-100.0%
Bear Case11.0x10.0x$-63.9M$-65.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-63.9M$-93.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 10 hospitals with 218-870 beds
  • Same-state prioritization (n=11)
  • Comp margins: P25=-15.0% / P50=-11.0% / P75=-5.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.